Anna M. Eiring

Center of Emphasis in Cancer

Title: A Role for Proteasome 26S Subunit, Non-ATPase 3 (PSMD3), in Disease Progression and Drug Resistance of Myeloid Leukemia

---

Biography

Dr. Anna Eiring is an Assistant Professor in the Department of Molecular and Translational Medicine at Texas Tech University Health Sciences Center in El Paso, Texas, a Title V Hispanic-serving institution. Her lab focuses on disease progression and drug resistance in myeloid leukemias driven by constitutively active tyrosine kinases, namely BCR-ABL1-driven chronic myeloid leukemia (CML) and FLT3-mutated acute myeloid leukemia (AML). She has published nearly 50 papers on cancer biology and immunology, and has further interests in understanding the biology underlying worse outcomes for minority cancer patients. 

Abstract